Fig. 1: Overview on the study design.
From: Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients
Tumor and normal DNA of 30 patients were distributed by DKFZ and NCT Heidelberg to four participating NGS laboratories. Bioinformatic analysis was performed at five participating departments. Additionally, all sequencing data were collected and analyzed with the same bioinformatic pipeline (blue arrows). Therapeutic relevant results from the DKFZ/NCT/DKTK MASTER program were collected and included in the comparative analysis.
